Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 tesla in phantom and in soft tissues of the abdomen

Journal of Computer Assisted Tomography

Volumn 37, Issue 1, 2013, Pages 46-51

  Corona Villalobos, Celia Pamela ^a   Pan, Li ^a,b   Halappa, Vivek Gowdra ^a   Bonekamp, Susanne ^a   Lorenz, Christine H ^a,b   Eng, John ^a   Kamel, Ihab R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

abdominal imaging; apparent diffusion coefficient; diffusion weighted imaging; phantom

Indexed keywords

HISTOLOGY; MAGNETIC RESONANCE IMAGING; MAGNETISM; MUSCLE; RESONANCE; SURFACE DIFFUSION;

ABDOMINAL IMAGING; APPARENT DIFFUSION COEFFICIENT; B VALUE; COEFFICIENT VALUES; COEFFICIENTS OF VARIATIONS; DIFFUSION WEIGHTED IMAGING; PARASPINAL MUSCLES; PHANTOMS; REPRODUCIBILITIES; SOFT TISSUE;

PHANTOMS;

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; COEFFICIENT OF VARIATION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DUAL B VALUE DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING; FEMALE; GALLBLADDER; HUMAN; KIDNEY; LIVER; MAJOR CLINICAL STUDY; MALE; MULTI B VALUE DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS; PRIORITY JOURNAL; RADIOLOGY PHANTOM; REPRODUCIBILITY; RETROSPECTIVE STUDY; SPLEEN; STATISTICAL PARAMETERS;

EID: 84872976386     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182720e07     Document Type: Article

References (34)

1. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275-282. (Pubitemid 39264807)
2. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging. 2006;6:135-143.
3. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217:331-345.
4. Braithwaite AC, Dale BM, Boll DT, et al. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0T diffusion-weighted imaging of the abdomen. Radiology. 2009;250:459-465.
5. Le Bihan D, Turner R, Douek P, et al. Diffusion MR imaging: Clinical applications. AJR Am J Roentgenol. 1992;159:591-599.
6. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999;9:53-60. (Pubitemid 29068231)
7. Matsubayashi RN, Fujii T, Yasumori K, et al. Apparent diffusion coefficient in invasive ductal breast carcinoma: Correlation with detailed histologic features and the enhancement ratio on dynamic contrast-enhanced MR images. J Oncol. 2010;2010:821048.
8. Kim SY, Lee SS, Byun JH, et al. Malignant hepatic tumors: Short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology. 2010;255:815-823.
9. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246:812-822.
10. Paudyal B, Paudyal P, Tsushima Y, et al. The role of the ADC value in the characterization of renal carcinoma by diffusion-weighted MRI. Br J Radiol. 2010;83:336-343.
11. Squillaci E,Manenti G, Cova M, et al. Correlation of diffusion-weighted MR imaging with cellularity of renal tumors. Anticancer Res. 2004;24:4175-4179. (Pubitemid 40468724)
12. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol. 2003;24:1627-1634. (Pubitemid 37151732)
13. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations. Neoplasia. 2009;11:102-125.
14. Perman WH, Balci NC, Akduman I, et al. Magnetic resonance measurement of diffusion in the abdomen. Top Magn Reson Imaging. 2009;20:99-104.
15. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging. 2007;25:848-858. (Pubitemid 46516739)
16. Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRIVa potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol. 2008;5:220-233. (Pubitemid 351493681)
17. Eichler AF, Batchelor TT, Henson JW. Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Neuro Oncol. 2007;9:373-377. (Pubitemid 47169670)
18. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology. J Clin Oncol. 2007;25:4104-4109. (Pubitemid 47495868)
19. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol. 2006;187:1521-1530. (Pubitemid 44788683)
20. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003;226:71-78. (Pubitemid 36163910)
21. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-178. (Pubitemid 34810055)
22. Merkle EM, Dale BM, Paulson EK. Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am. 2006;14:17-26. (Pubitemid 43363395)
23. Padhani AR, Koh DM. Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am. 2011;19:181-209.
24. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging. 2010;32:2-16.
25. Mardor Y, Pfeffer R, Spiegelmann R, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol. 2003;21:1094-1100. (Pubitemid 46594139)
26. Kwee TC, Takahara T, Ochiai R, et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol. 2008;18:1937-1952.
27. Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843-847. (Pubitemid 44205378)
28. Kamel IR, Reyes DK, Liapi E, et al. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18:49-56. (Pubitemid 46616678)
29. Padhani AR, Khan AA. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol. 2010;5:39-52.
30. Lorenz CH, Pickens DR 3rd, Puffer DB, et al. Magnetic resonance diffusion/perfusion phantom experiments. Magn Reson Med. 1991;19:254-260.
31. Dale BM, Braithwaite AC, Boll DT, et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol. 2010;45:104-108.
32. Koh DM, Padhani AR. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology. Magn Reson Imaging Clin N Am. 2010;18:565-585.
33. Rosenkrantz AB, Oei M, Babb JS, et al. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: Image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging. 2011;33:128-135.
34. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47-66.